Updated WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines in the context of limited supply
WHO encourages manufacturers to develop quality assured formulations of the game-changing drug rifapentine
WHO publishes new Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring
Manual for investigating suspected outbreaks of illnesses of possible chemical etiology: guidance for investigation and control
Statement on the eighth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic
New findings from the ODYSSEY trial confirm superiority of dolutegravir-based ART in young children
Launch WHO guidelines for the management of symptomatic sexually transmitted infections
WHO warns that HIV infection increases risk of severe and critical COVID-19
